BRCA1-associated structural variations are a consequence of polymerase theta-mediated end-joining
Cancer mutational signatures have been associated with defects in genome maintenance pathways. Here the authors, by using a worm germline mutagenesis model defective of human orthologue BRCA-1, identify polymerase theta-mediated end-joining (TMEJ) as causing the BRCAness mutational signature.
Guardado en:
Autores principales: | J. A. Kamp, R. van Schendel, I. W. Dilweg, M. Tijsterman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7e9ffb55af7f4b2f9a5cfebaf60ef6ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BRCA2 antagonizes classical and alternative nonhomologous end-joining to prevent gross genomic instability
por: Jinhua Han, et al.
Publicado: (2017) -
Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining
por: Tzah Feldman, et al.
Publicado: (2021) -
Genetic determinants of cellular addiction to DNA polymerase theta
por: Wanjuan Feng, et al.
Publicado: (2019) -
Molecular basis of microhomology-mediated end-joining by purified full-length Polθ
por: Samuel J. Black, et al.
Publicado: (2019) -
Clinical consequences of BRCA2 hypomorphism
por: Laia Castells-Roca, et al.
Publicado: (2021)